• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
    • Bullous Pemphigoid Learning Hub
    • COPD Learning Hub
    • Prurigo Nodularis Learning Hub
    • Rhinology Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Your Catalyst Learning Hub: Advancing Respiratory Treatment Paradigms
    • Your Navigator Learning Hub: Guiding Personalized Patient Journeys
    • Your Steward Learning Hub: Upholding Excellence in Everyday Practice
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
Dermatology
10 min
expert video

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
Dermatology
24 min
expert video

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
3 min
Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

The Burden in Patients with CRSwNP and Coexisting Asthma
Pulmonology
8 min
expert video

The Burden in Patients with CRSwNP and Coexisting Asthma

EoE Quest: Navigating the Patient Experience
Gastroenterology
12 min
interactivity

EoE Quest: Navigating the Patient Experience

Spotlight on Type 2 Inflammation in the Upper and Lower Airways
Pulmonology
4 min
expert video

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

Compounded Burden of Co-existing Type 2 Airway Diseases
Pulmonology
4 min
expert video

Compounded Burden of Co-existing Type 2 Airway Diseases

Gastro Forum 2025 | EoE: How Far We've Come
Gastroenterology
24 min
videoanimation

Gastro Forum 2025 | EoE: How Far We've Come

ESPGHAN 2025 Pediatric EoE: Early Identification & Type 2 Comorbidity
Gastroenterology
14 min
expert video

ESPGHAN 2025 Pediatric EoE: Early Identification & Type 2 Comorbidity

Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
4 min
expert video

Type 2 Inflammation Contributes to Itch and Fibrois in PN

How the Understanding of PN has Evolved?
Dermatology
2 min
expert video

How the Understanding of PN has Evolved?

Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
Dermatology
2 min
expert video

Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients

    1
    ...
    101112
    ...
    23